1. Introduction
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Australia Flu Diagnostic and Treatment Market By Type of Flu
5.1. Introduction
5.2. Type A
5.3. Type B
6. Australia Flu Diagnostic and Treatment Market By Age Group
6.1. Introduction
6.2. 0-14 Years
6.3. 15-64 Years
6.4. >=65 Years
7. Australia Flu Diagnostic and Treatment Market By End-User
7.1. Introduction
7.2. Hospital Laboratory
7.3. Outpatient Clinic
7.4. Reference Laboratory
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Abbott
9.2. F. Hoffmann-La Roche Ltd
9.3. BD
9.4. Thermo Fisher Scientific Inc.
9.5. 3M